Renal dysfunction is an independent risk factor for bleeding after gastric ESD

Background and study aims: The number of patients with chronic kidney disease (CKD) is increasing worldwide and gastric cancer sometimes occurs with CKD. However, the safety and feasibility of endoscopic submucosal dissection (ESD) for patients with CKD are not clear. The aim of this study is to clarify the feasibility and safety of gastric ESD for patients with CKD.

Patients and methods: This was a multicenter retrospective cohort study. In total, 144 patients with CKD who underwent gastric ESD between May 2003 and October 2012 were enrolled. The patients were divided into three groups: stage 3 (estimated glomerular filtration rate [eGFR]: 30 – 59 mL/min), stage 4 (eGFR: 15 – 29 mL/min), and stage 5 (eGFR: < 15 mL/min) according to the Kidney Disease Improving Global Outcomes Guidelines. The en bloc and curative resection rates and complications were assessed as short-term outcomes. Overall survival was analyzed using Kaplan – Meier methods.

Results: In total, 92 patients were in stage 3 CKD; 23 in stage 4; and 29 in stage 5, including 19 patients in hemodialysis. The en bloc resection rate was 95.8 %. Post-ESD bleeding was observed in four patients with stage 5 CKD (13.8 %), three with stage 4 (13.0 %), and one with stage 3 (1.1 %). All bleeding could be controlled by endoscopic hemostasis, but five patients required blood transfusion. Perforation occurred in two patients (6.9 %) with stage 5 CKD, none (0 %) with stage 4, and two (4.3 %) with stage 3. Multivariate Poisson regression analysis revealed CKD stage 4 was a critical factor related to bleeding, whereas diabetes mellitus and CKD stage 5, which largely consist of patients receiving hemodialysis, were not. The median observation period of patients who achieved curative resection was 25.9 months (range 0.8—112.7 months) and the 3-year overall survival rate was 92.5 %.

Conclusions: Estimated GFR is a significant independent predictive factor of post-ESD bleeding in patients with CKD.

• References

• 1 Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004; 31: 450-464
• 2 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362
• 3 Fock KM, Talley N, Moayyedi P et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-365
• 4 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-123
• 5 Akasaka T, Nishida T, Tsutsui S et al. Short-term outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasm: multicenter survey by Osaka University ESD study group. Dig Endosc 2011; 23: 73-77
• 6 Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol 2009; 13: 537-566
• 7 Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992
• 8 Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28
• 9 Miller WG. Estimating glomerular filtration rate [Editorial]. Clin Chem Lab Med 2009; 47: 1017-1019
• 10 Stevens LA, Coresh J, Greene T et al. Assessing kidney function measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483
• 11 Yasuda K, Tahara K, Kume M et al. Risk factors for morbidity and mortality following abdominal surgery in patients on maintenance hemodialysis. Hepatogastroenterology 2007; 54: 2282-2284
• 12 Wind P, Douard R, Rouzier R et al. Abdominal surgery in chronic hemodialysis patients. Am Surg 1999; 65: 347-351
• 13 Ogoshi K, Kaneko E, Tada M et al. The management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastroenterol Endosc 2005; 47: 2691-2695
• 14 Cherng YG, Liao CC, Chen TH et al. Are non-cardiac surgeries safe for dialysis patients? – A population-based retrospective cohort study. PLoS One 2013; 8: e58942
• 15 Luo JC, Leu HB, Hou MC et al. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients. Am J Med 2013; 126: 264.e25-e32
• 16 Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial 2006; 19: 317-322
• 17 Hörl WH. Thrombocytopathy and blood complications in uremia. Wien Klin Wochenschr 2006; 118: 134-150
• 18 Luo JC, Leu HB, Huang KW et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011; 183: E1345-1351
• 19 Higashiyama M, Oka S, Tanaka S et al. Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm. Dig Endosc 2011; 23: 290-295
• 20 Toyokawa T, Inaba T, Omote S et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 2012; 27: 907-912
• 21 Soyoral YU, Demir C, Begenik H et al. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis. Clin Appl Thromb Hemost 2012; 18: 185-188
• 22 Winkelmayer WC, Levin R, Avorn J. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis 2003; 41: 84-89
• 23 Numata N, Oka S, Tanaka S et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease. J Gastroenterol Hepatol 2013; 28: 1632-1637
• 24 Kwon YL, Kim ES, Lee KI et al. Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis. Surg Endosc 2011; 25: 1994-1999
• 25 Goto O, Fujishiro M, Kodashima S et al. Feasibility of endoscopic submucosal dissection for patients with chronic renal failure on hemodialysis. Dig Endosc 2010; 22: 45-48
• 26 Nayman J. Effect of renal failure on wound healing in dogs. Response to hemodialysis following uremia induced by uranium nitrate. Ann Surg 1966; 164: 227-235
• 27 Cheung AH, Wong LM. Surgical infections in patients with chronic renal failure. Infect Dis Clin North Am 2001; 15: 775-796
• 28 Choi CW, Kim HW, Kang DH et al. Clinical outcomes of second-look endoscopy after gastric endoscopic submucosal dissection: predictive factors with high risks of bleeding. Surg Endosc 2014; 28: 2213-2220
• 29 Kato M, Nishida T, Yamamoto K et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut 2013; 62: 1425-1432
• 30 Kohli Y, Kawai K, Fujita S. Analytical studies on growth of human gastric cancer. J Clin Gastroenterol 1981; 3: 129-133